
David Kane to lead CCC’s Biosector 2
pharmafile | June 22, 2011 | Appointment | Medical Communications | appointment, medical communications
Chandler Chicco Companies (CCC) has appointed David Kane as managing director of its healthcare PR agency Biosector 2.
He moves to the agency in August from Ogilvy Healthworld where he was global brand leader for Boehringer Ingelheim and a senior member of the global medical education team
In his new role David will report to Chandler Chicco Companies’s European operations director Fiona Hall.
She said: “We are thrilled to have David as the newest member of our senior team. As our clients look to redefine their business models in the face of mounting and multiple pressures, Chandler Chicco Companies has a duty to be at the forefront of formulating new services and ways to meet client needs. David’s appointment is just one of the exciting steps we are taking to do this.”
Biosector 2’s former managing director Neil Beasley will take on a newly-created strategic client services and development role, working across the entire Chandler Chicco Companies network.
Related Content

Men’s health – a new report from the Department of Health and Social Care
The UK Department of Health and Social Care has published a new report entitled Men’s …

PlasmidFactory founder Dr. Martin Schleef honoured with the NRW Innovation Award 2025
The founder and long-standing CEO of PlasmidFactory, Dr. Martin Schleef, was honoured in Düsseldorf with …

David Wheadon appointed to board of directors at Seaport Therapeutics
This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.






